Urinary schistosomiasis

Pediatric Nephrology

Volumn 29, Issue 11, 2014, Pages 2113-2120

  Bamgbola, Oluwatoyin F ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Pediatric tropical disease; Schistosomal glomerulopathy; Urinary schistosomiasis

Indexed keywords

EID: 84892726617     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2723-1     Document Type: Article

References (44)

1. World Health Organization (2013) Schistosomiasis. Fact sheet no. 115. World Health Organization, Geneva, Switzerland. Available at: http://www.who.int/mediacentre/factsheets/fs115/en/
2. Gryseels B, Polman K, Clerinx J, Kestens L (2006) Human schistosomiasis. Lancet 368(9541):1106–1118
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6(7):411–425
4. Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J (2013) Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol 29(4):197–205
5. Ganley-Leal LM, Mwinzi PN, Cetre-Sossah CB, Andove J, Hightower AW, Karanja DM, Colley DG, Secor WE (2006) Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun 74(4):2169–2176
6. Naus CWA, van Dam GV, Kremsner PG, Krijger FW, Deelder AM (1998) Human IgE, IgG subclass, and IgM responses to worm and egg antigens in Schistosomiasis haematobium: A 12-month study of reinfection in Cameroonian children. Clin Infect Dis 26:1142–1147
7. Miller P, Wilson RA (1980) Migration of the schistosomula of Schistosoma mansoni from the lungs to the hepatic portal system. Parasitology 80(2):267–288
8. Schroeder H, Skelly P, Zipfel PF, Losson B, Vanderplasschen A (2009) Subversion of complement by hematophagous parasites. Dev Comp Immunol 33(1):5–13
9. Cheever AW, Hoffmann KF, Wynn TA (2000) Immunopathology of Schistosomiasis mansoni in mice and men. Immunol Today 21:465–466
10. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA (2007) Immunopathology of schistosomiasis. Immunol Cell Biol 85(2):148–154
11. Ouf EA, Ojurongbe O, Akindele AA, Sina-Agbaje OR, Van Tong H, Adeyeba AO, Kremsner PG, Kun JF, Velavan T (2012) Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. J Infect Dis 206(4):562–570
12. Nicolls DJ, Weld LH, Schwartz E, Reed C, von Sonnenburg F, Freedman DO, Kozarsky PE (2008) Characteristics of Schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997–2008. Am J Trop Med Hyg 79(5):729–734
13. Appleton CC (1984) Schistosome dermatitis: an unrecognized problem in South Africa? S Afr Med J 65:467–469
14. Jones MK, McManus DP, Sivadorai P, Glanfield A, Moertel L, Belli SI, Gobert GN (2007) Tracking the fate of iron in early development of human blood flukes. Int J Biochem Cell Biol 39(9):1646–1658
15. Ayoya MA, Spiekermann-Brouwer GM, Stoltzfus RJ, Nemeth E, Habicht JP, Ganz T, Rawat R, Traoré AK, Garza C (2010) α1-Acid glycoprotein, hepcidin, C-reactive protein, and serum ferritin are correlated in anemic schoolchildren with Schistosoma haematobium. Am J Clin Nutr 91(6):1784–1790
16. Khalaf I, Shokeir A, Shalaby M (2012) Urologic complications of genitourinary schistosomiasis. World J Urol 30(1):31–38
17. Hegertun IE, Sulheim Gundersen KM, Kleppa E, Zulu SG, Gundersen SG, Taylor M, Kvalsvig JD, Kjetland EF (2013) S. haematobium as a common cause of genital morbidity in girls: A cross-sectional study of children in South Africa. PLoS Negl Trop 7(3):e2104
18. Bottieau E, Clerinx J, de Vega MR, Van den Enden E, Colebunders R, Van Esbroeck M, Vervoort T, Van Gompel A, Van den Ende J (2006) Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect 52:339–345
19. Carod-Artal FJ (2008) Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 102:107–116
20. Dobardzic AM, Dobardzic R (1997) Epidemiological features of complicated UTI in a district hospital of Kuwait. Eur J Epidemiol 13(4):465–470
21. Nmorsi OP, Kwandu UN, Ebiaguanye LM (2007) Schistosoma haematobium and urinary tract pathogens co-infections in a rural community of Edo State, Nigeria. J Commun Dis 39(2):85–90
22. Barnhill AE, Novozhilova E, Day TA, Carlson SA (2011) Schistosoma-associated Salmonella resist antibiotics via specific fimbrial attachments to the flatworm. Parasit Vectors 4:123
23. Fedewa SA, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Nriagu J, Wilson ML (2009) Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol 33(3–4):176–181
24. Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML (2008) The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 19(4):421–429
25. Seck SM, Sarr ML, Dial MC, Ka EF (2011) Schistosoma hematobium-associated glomerulopathy. Indian J Nephrol 21(3):201–203
26. dos-Santos WL, Sweet GM, Bahiense-Oliveira M, Rocha PN (2011) Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil. Mem Inst Oswaldo Cruz 106(7):901–904
27. Sobh M, Moustafa F, El Arbagy A, El Din MS, Shamaa S, Amer G (1990) Nephropathy in asymptomatic patients with active Schistosoma mansoni infection. Int Urol Nephrol 22:37–43
28. Madwar MA, O'Shea JM, Skelton JA, Soothill JF (1978) Complement components and immunoglobulins in patients with schistosomiasis. Clin Exp Immunol 34:354–358
29. Feldmeier H, Poggensee G (1993) Diagnostic techniques in Schistosomiasis control: a review. Acta Trop 52:205–220
30. Leutscher PD, Reimert CM, Vennervald BJ, Ravaoalimalala VE, Ramarokoto CE, Serieye J, Raobelison A, Rasendramino M, Christensen NO, Esterre P (2000) Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine. Trop Med Int Health 5:88–93
31. Bichler KH, Savatovsky I (2006) EAU guidelines for the management of urogenital schistosomiasis. Eur Urol 49(6):939–1152
32. Fritzsche C, Stachs O, Holtfreter MC, Nohr-Łuczak C, Guthoff RF, Reisinger EC (2012) Confocal laser scanning microscopy, a new in vivo diagnostic tool for Schistosomiasis. PLoS One 7(4):e34869
33. Kinkel HF, Dittrich S, Bäumer B, Weitzel T (2012) Evaluation of eight serological tests for diagnosis of imported schistosomiasis. Clin Vaccine Immunol 19(6):948–953
34. Tchuem Tchuenté L-A, Kueté Fouodo CJ, Kamwa Ngassam RI, Sumo L, Dongmo Noumedem C, Kenfack CM, Gipwe NF, Nana ED, Stothard JR, Rollinson D (2012) Evaluation of circulating cathodic ntigen (CCA) urine—tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl Trop Dis 6(7):e1758
35. Ibironke OA, Phillips AE, Garba A, Lamine SM, Shiff C (2011) Diagnosis of Schistosoma haematobium by detection of specific DNA fragments from filtered urine samples. Am J Trop Med Hyg 84(6):998–1001
36. Fenwick A, Savioli L, Engels D, Robert BN, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509–515
37. Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M (2012) Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia. Asian Pac J Trop Biomed 2(3):235–239
38. Stothard JR, Sousa-Figueiredo JC, Betson M, Green HK, Seto EY, Garba A, Sacko M, Mutapi F, Vaz Nery S, Amin MA, Mutumba-Nakalembe M, Navaratnam A, Fenwick A, Kabatereine NB, Gabrielli AF, Montresor A (2011) Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 138(12):1593–1606
39. Castro N, Jung H, Medina R, González-Esquivel D, Lopez M, Sotelo J (2002) Interaction between grapefruit juice and praziquantel in humans. Antimicrob Agents Chemother 46(5):1614–1616
40. Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL (2006) The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci 29(1):70–81
41. Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, García HH, Yang GJ, Sripa B, Lustigman S (2012) A research agenda for Helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6(4):e1549
42. King CH, Olbrych SK, Soon M, Singer ME, Carter J (2011) Colley DG (2011) Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis 5(9):e1321
43. Pearson MS, Pickering DA, McSorley HJ, Bethony JM, Tribolet L, Dougall AM, Hotez PJ, Loukas A (2012) Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis 6(3):e1564
44. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, Wolf RF, White GL, Carey DW, Mwinzi PN, Ganley-Leal L, Kennedy RC, Siddiqui AA (2011) Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis 204(9):1437–1444